Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.40 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.39 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.37 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29846595 | 0.91 | EZH2 (0.49) | LMNACNR1EZH2 | |
| SCHEMBL29846578 | 0.88 | BCHE (0.49) | LMNACNR1KLKB1PTPN7BRD4 | |
| SCHEMBL29846830 | 0.83 | HTR4 (0.54) | HTR4 | |
| SCHEMBL29846604 | 0.82 | EZH2 (0.51) | EZH2HTR4 | |
| SCHEMBL29846797 | 0.81 | HDAC3 (0.41) | LMNACNR1BRD4BCHEACHE | |
| SCHEMBL29846735 | 0.78 | PPARG (0.48) | LMNA | |
| SCHEMBL29846819 | 0.78 | ALDH1A1 (0.50) | LMNAGAAHTR4 | |
| SCHEMBL29846668 | 0.78 | KLKB1 (0.42) | GAAKLKB1BRD4 | |
| SCHEMBL29846644 | 0.77 | KLKB1 (0.42) | LMNAKLKB1 | |
| SCHEMBL29846439 | 0.77 | SMN1; SMN2 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022123530-A1 | BORONIC ACID COMPOUND | 주식회사 엘지화학 | 2022-06-16 | — | — | WO | disclosed |